David C. Sachs - 22 Feb 2026 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Role: Chief Financial Officer
Signature: /s/ Philip LoScalzo, as Attorney-in-Fact
Issuer symbol: IBRX
Transactions as of: 22 Feb 2026
Net transactions value: -$179,933
Form type: 4
Filing time: 24 Feb 2026, 20:05:12 UTC
Previous filing: 12 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sachs David C.	Chief Financial Officer	C/O IMMUNITYBIO, INC., 3530 JOHN HOPKINS COURT, SAN DIEGO	/s/ Philip LoScalzo, as Attorney-in-Fact	24 Feb 2026	0001848899

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IBRX	Common Stock	Options Exercise	$0	+40,650	+15%	$0.000000	320,825	22 Feb 2026	Direct	F1
transaction	IBRX	Common Stock	Tax liability	$179,933	-20,682	-6.4%	$8.70	300,143	22 Feb 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IBRX	Restricted Stock Units	Options Exercise	$0	-40,650	-50%	$0.000000	40,651	22 Feb 2026	Common Stock	40,650		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. (the "Issuer") common stock.
F2	On February 22, 2026, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on February 20, 2026 was the settlement price used to calculate the shares withheld.
F3	Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024.